Quetiapine (Seroquel): sedation, sleep, and broad clinical use

Quetiapine, sold most commonly as Seroquel and Seroquel XR, is among the most prescribed antipsychotics in the United States. It is approved for schizophrenia, bipolar disorder, and as adjunct therapy for major depression, and it is also widely — and somewhat controversially — prescribed off-label for insomnia and anxiety. Its defining feature is sedation: at low doses it functions almost entirely as a sleep aid, while at higher doses it becomes a serious antipsychotic.

What quetiapine is

Quetiapine is a "dibenzothiazepine" antipsychotic, originally approved by the FDA in 1997. It is available as immediate-release Seroquel and extended-release Seroquel XR, both as generics. The full FDA prescribing information is available through Drugs@FDA.

How it works

Quetiapine binds many receptors, but its profile is dominated by potent histamine H1 blockade (responsible for sedation), strong serotonin 5-HT2A blockade, and only modest dopamine D2 blockade. This makes it less likely than first-generation antipsychotics to cause stiffness or movement disorders, but more likely to cause sedation, weight gain, and orthostatic hypotension. Its active metabolite, norquetiapine, also blocks the norepinephrine transporter — a mechanism similar to some antidepressants, which may contribute to its mood effects.

What it treats

• Schizophrenia in adults and adolescents
• Bipolar I disorder — acute mania, acute depression, and maintenance
• Major depressive disorder — as adjunctive therapy with an antidepressant
• Bipolar depression — one of the few medications with this specific approval

Off-label uses include insomnia, generalised anxiety, post-traumatic stress disorder, and agitation in dementia (the last with significant safety concerns, particularly mortality risk in elderly patients with dementia).

Typical dosing range

FDA labelled adult dose ranges vary by indication. For schizophrenia, the labelled range is typically 150 to 750 mg per day. For bipolar mania, similar. For bipolar depression, 300 mg per day is the labelled target. For depression as an adjunct, 150 to 300 mg. Off-label sleep doses (25 to 100 mg at bedtime) are far lower than antipsychotic doses. Specific dosing should always be set by your prescriber.

Quetiapine has a relatively short half-life (around 6 hours for immediate-release, longer for XR), which is why immediate-release is often divided into multiple daily doses for schizophrenia.

The off-label sleep question

Quetiapine is one of the most-prescribed off-label medications for insomnia in the United States. There are real concerns about this practice:

• Even at low "sleep" doses, it can cause weight gain and metabolic changes
• It carries the same boxed warnings as at higher doses
• Better-studied insomnia treatments exist

Many sleep specialists and primary care guidelines (including from the American Academy of Sleep Medicine) explicitly recommend against routine off-label use of quetiapine for insomnia. If you are taking it primarily for sleep, this is worth discussing with your prescriber.

Common side effects

• Sedation — almost universal, especially at the start; often improves over weeks
• Weight gain — moderate to substantial, particularly in the first 6 months
• Dry mouth
• Orthostatic hypotension and dizziness
• Increased appetite, particularly carbohydrate cravings
• Constipation
• Headache

Serious side effects

Quetiapine carries the standard antipsychotic boxed warnings (increased mortality in elderly with dementia-related psychosis; suicidality in young adults treated for depression). It also has notable risks of:

• Metabolic syndrome — type 2 diabetes, dyslipidaemia, abdominal obesity (see our metabolic syndrome guide)
• QT prolongation — caution with other QT-prolonging drugs and with cardiac risk factors
• Tardive dyskinesia — lower risk than first-generation antipsychotics but still possible
• Neuroleptic malignant syndrome — rare but a medical emergency
• Cataracts — periodic eye exams are recommended on the FDA label

What patients commonly say

• "It knocked me out — I slept for 12 hours the first night."
• "I gained 30 pounds in 8 months and my cholesterol went up."
• "It worked for my mania faster than anything else I'd tried."
• "I was put on a low dose for sleep and have been on it 5 years; I'm not sure how to stop now."

Questions for your prescriber

• What's the target dose, and what condition are we treating?
• If this is for sleep only, are there other options that might be safer long-term?
• How often will my weight, blood sugar, and lipids be checked?
• Should I get a baseline ECG?
• How would we taper if we decide to stop?

Putting it together

Quetiapine is a useful and broadly approved antipsychotic. Its sedating profile makes it especially helpful for patients with prominent insomnia or agitation accompanying their condition. But the metabolic burden is real, and the off-label sleep use deserves a more critical look than it has historically received. As with all antipsychotics, the right choice is the one made carefully with a prescriber who tracks the full picture.

This article is for educational purposes only and is not medical advice. Information is summarised from publicly available FDA labelling and peer-reviewed literature. Always consult your prescribing clinician before starting, stopping, or changing any medication. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.